NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1
- PMID: 28831766
- PMCID: PMC5594049
- DOI: 10.1007/s12104-017-9768-1
NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1
Abstract
Neurofibromin and Sprouty-related EVH1 domain-containing protein 1 (Spred1) both act as negative regulators of the mitogen-activated protein kinase pathway and are associated with the rare diseases Neurofibromatosis type 1 and Legius syndrome, respectively. Spred1 recruits the major GTPase activating protein (GAP) neurofibromin from the cytosol to the membrane in order to inactivate the small G protein Ras. These functions are dependent on the N-terminal EVH1 domain and the C-terminal Sprouty domain of Spred1 whereas the former specifically recognizes the GAP related domain of neurofibromin and the latter is responsible for membrane targeting. Within the GAP domain, Spred1 binding depends on the GAPex portion which is dispensable for Ras inactivation. In a first step towards the characterization of the Neurofibromin Spred1 interface in solution we assigned backbone and side chain 1H, 13C, and 15N chemical shifts of the Spred1 derived EVH1 domain. Our chemical shift data analysis indicate seven consecutive β-strands followed by a C-terminal α-helix which is in agreement with the previously reported crystal structure of Spred1(EVH1). Our data provide a framework for further analysis of the function of patient-derived mutations associated with rare diseases.
Keywords: Legius syndrome; NMR resonance assignment; Protein purification; TALOS+ prediction.
Figures


Similar articles
-
Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.J Biol Chem. 2016 Feb 12;291(7):3124-34. doi: 10.1074/jbc.M115.703710. Epub 2015 Dec 3. J Biol Chem. 2016. PMID: 26635368 Free PMC article.
-
The neurofibromin recruitment factor Spred1 binds to the GAP related domain without affecting Ras inactivation.Proc Natl Acad Sci U S A. 2016 Jul 5;113(27):7497-502. doi: 10.1073/pnas.1607298113. Epub 2016 Jun 16. Proc Natl Acad Sci U S A. 2016. PMID: 27313208 Free PMC article.
-
Pathogenic Mutations Associated with Legius Syndrome Modify the Spred1 Surface and Are Involved in Direct Binding to the Ras Inactivator Neurofibromin.J Mol Biol. 2019 Sep 6;431(19):3889-3899. doi: 10.1016/j.jmb.2019.07.038. Epub 2019 Aug 8. J Mol Biol. 2019. PMID: 31401120
-
Legius syndrome, an Update. Molecular pathology of mutations in SPRED1.Keio J Med. 2013;62(4):107-12. doi: 10.2302/kjm.2013-0002-re. Epub 2013 Dec 10. Keio J Med. 2013. PMID: 24334617 Review.
-
Review and update of SPRED1 mutations causing Legius syndrome.Hum Mutat. 2012 Nov;33(11):1538-46. doi: 10.1002/humu.22152. Epub 2012 Aug 1. Hum Mutat. 2012. PMID: 22753041 Review.
Cited by
-
SPRED2 loss-of-function causes a recessive Noonan syndrome-like phenotype.Am J Hum Genet. 2021 Nov 4;108(11):2112-2129. doi: 10.1016/j.ajhg.2021.09.007. Epub 2021 Oct 8. Am J Hum Genet. 2021. PMID: 34626534 Free PMC article.
-
Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia.Leukemia. 2021 Aug;35(8):2285-2298. doi: 10.1038/s41375-021-01166-9. Epub 2021 Feb 15. Leukemia. 2021. PMID: 33589748 Free PMC article.
-
SPRED proteins and their roles in signal transduction, development, and malignancy.Genes Dev. 2020 Nov 1;34(21-22):1410-1421. doi: 10.1101/gad.341222.120. Genes Dev. 2020. PMID: 33872193 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous